NCT02028871已完成2 期
Intranasal Insulin for Weight Management During Smoking Cessation
Ajna Hamidovic1 个研究点 分布在 1 个国家目标入组 26 人开始时间: 2014年7月最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 26
- 试验地点
- 1
- 主要终点
- Amount Eaten in Taste Test
研究概览
简要总结
This FDA-approved (IND# 120700) study will evaluate efficacy of intranasal insulin in reducing snack intake and reducing postprandial free fatty acid levels in abstinent smokers.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •smokers (>10 cig/day) for the past 1 year
- •normosmic olfactory function
排除标准
- •previous/current use of insulin
- •current Diagnostic and Statistical Manual-IV-Revised (DSM-IV-R) Axis I disorder
- •current pregnancy (or lactation)
- •lifetime history of endocrine disease
- •excessive alcohol use (>25 standard units of alcohol/week)
- •current use of illicit drugs
- •current use of a smoking cessation aid (NRT, Chantix or Wellbutrin), or a psychotropic agent
- •local infections, inflammation, structural abnormalities, or other nasal pathology
- •current use of any medications administered intranasally, including intranasal steroids
研究组 & 干预措施
Intranasal Insulin First
Active Comparator
Intranasal Insulin First, Placebo Second
干预措施: Intranasal Insulin (Drug)
Placebo First
Placebo Comparator
Placebo First, Intranasal Insulin Second
干预措施: Placebo (Drug)
结局指标
主要结局
Amount Eaten in Taste Test
时间窗: 90 minutes
次要结局
未报告次要终点
研究者
Ajna Hamidovic
Assistant Professor
University of New Mexico
研究点 (1)
Loading locations...
相似试验
已完成
1 期
Intranasal Insulin for Improving Cognitive Function in Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Secondary ProgressiveMultiple Sclerosis, Primary ProgressiveNCT02988401Johns Hopkins University105
已完成
3 期
Effect of Intranasal Insulin on Depressive Symptoms in Major Depressive DisorderMajor Depressive DisorderNCT00570050University Health Network, Toronto35
已完成
2 期
Study of Nasal Insulin to Fight Forgetfulness - Device StudyMild Cognitive ImpairmentCognitive ImpairmentNCT03857321Wake Forest University Health Sciences20
招募中
2 期
Evaluating the effect of intranasal insulin administration on motor and non-motor symptoms in Parkinson’s disease patients; a randomized double-blinded placebo-controlled clinical trialIRCT20191022045196N1Shahid Beheshti University of Medical Sciences40
招募中
2 期
COMMETS- Combination MCI Metabolic SyndromeMild Cognitive ImpairmentMetabolic SyndromeAlzheimer DiseaseNCT06072963Rutgers, The State University of New Jersey80